Genentech to Present New Data on Personalized Medicines and Cancer Immunotherapies at the 2017 American Society of Clinical Oncology ASCO Annual Meeting

20 Genentech medicines are included in more than 190 abstracts during ASCO 2017 New pivotal results for Perjeta pertuzumab and Alecensa alectinib demonstrating improvement over standards of care ...